By Sven Larsen (@svenplarsen)
Frustrated with the wait for FDA social media guidelines? Trying to make sense of the Sunshine Act?
You’re not alone. In fact, those concerns are shared by just about every person involved in Pharma or healthcare these days. Despite the widespread demand for some sort of government response, Washington remains almost defiantly silent.
But not everyone is willing to just sit back and wait. As part of Social Media Week New York, a bunch of our industry’s best and brightest (including reps from Pixels & pills) came together to create a series of recommendations for the FDA. Led by Marc Monseau of MDM Communications and Tom Cherniak of Cmp.ly, the session framed up the issues at hand and then broke in to smaller working groups in order to generate solutions. It was a fascinating process and you can see the results in this wiki that was created to capture the meeting output:
It was a fascinating process that helped identify some common beliefs throughout our industry and some eminently practical next steps that the FDA could take to address some of the challenges facing our industry.
Perhaps we should include sessions like this at all the major Pharma conferences.
What do you think? If the industry repeatedly made it’s voice heard with the FDA would it finally generate the pressure required to evoke some sort of response?